Skip to content
Research Article Open access CC BY 4.0

The Effect of Immunosuppression on Kaposi Sarcoma: A Case Series

Rita Nkiru Ajirenike, Amaewhule Mary Nnneda, Dasetima D. Altraide, Figilo Ibeinmo Moses, Amadi Ekechi Stella, Johnson Mine, Ogbu Christian.

International Research Journal of Oncology · pp. 233–238 · Published 29 Oct 2024

Abstract

Kaposi sarcoma (K.S) is a rare type of cancer with four clinical variants which has a link to Human Herpes Virus (HHV-8) in the etiology. Commonly seen are the acquired immunodeficiency syndrome (AIDS) -related variants. Kaposi Sarcoma occurring after solid-organ transplant is a cause of public health concern as immunosuppressive medications especially the Calcineurin inhibitors play a key role in the development of Kaposi Sarcoma after organ transplantation. In this series, six patients with Kaposi Sarcoma were presented. Four patients had retro-viral disease; sero-positive to HIV 1 & 2 who were not compliant with their Highly Active Retro-viral Therapy (HAART), a male patient with post-transport K.S, and a case of suspected classic K.S. In patients with Kaposi Sarcoma, early detection and switching Transplant recipient on Calcineurin inhibitors to mTOR inhibitors are basic parameters for successful management.

Kaposi Sarcoma Retroviral disease (RVD) renal transplantation Calcineurin inhibitors mTOR inhibitors

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.